106 related articles for article (PubMed ID: 31383989)
1. Author Correction: Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
Acta Pharmacol Sin; 2020 Apr; 41(4):581-582. PubMed ID: 31383989
[TBL] [Abstract][Full Text] [Related]
2. Author Correction: Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2019 Aug; 40(8):1127-1128. PubMed ID: 31097762
[TBL] [Abstract][Full Text] [Related]
3. Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions.
Yan W; Tu B; Liu YY; Wang TY; Qiao H; Zhai ZJ; Li HW; Tang TT
Bone Res; 2013 Dec; 1(4):362-70. PubMed ID: 26273514
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma.
Zhang C; Huang H; Zhang J; Wu Q; Chen X; Huang T; Li W; Liu Y; Zhang J
Cell Death Dis; 2019 Jul; 10(8):572. PubMed ID: 31358729
[TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-κB-dependent matrix metalloproteinase-9 expression.
Zhai Z; Qu X; Li H; Ouyang Z; Yan W; Liu G; Liu X; Fan Q; Tang T; Dai K; Qin A
Mol Med Rep; 2019 Mar; 19(3):1979. PubMed ID: 30628678
[TBL] [Abstract][Full Text] [Related]
6. [Erratum] Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro.
Yamaguchi M; Murata T
Mol Med Rep; 2018 Feb; 17(2):3432. PubMed ID: 29257315
[TBL] [Abstract][Full Text] [Related]
7. Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling.
Usman MW; Gao J; Zheng T; Rui C; Li T; Bian X; Cheng H; Liu P; Luo F
Cell Death Dis; 2019 Jun; 10(7):501. PubMed ID: 31235854
[TBL] [Abstract][Full Text] [Related]
8. [Corrigendum] USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β‑catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2019 Nov; 55(5):1176. PubMed ID: 31485660
[TBL] [Abstract][Full Text] [Related]
9. Author Correction: Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells.
Gao Y; Zhang Z; Li K; Gong L; Yang Q; Huang X; Hong C; Ding M; Yang H
Cell Death Dis; 2019 Aug; 10(8):604. PubMed ID: 31406116
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
Asian Pac J Cancer Prev; 2017 Nov; 18(10):2895-2895. PubMed ID: 29171745
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: 2600-years of stratospheric volcanism through sulfate isotopes.
Gautier E; Savarino J; Hoek J; Erbland J; Caillon N; Hattori S; Yoshida N; Albalat E; Albarede F; Farquhar J
Nat Commun; 2019 Jun; 10(1):2663. PubMed ID: 31209219
[TBL] [Abstract][Full Text] [Related]
12. Correction: In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects.
Jiang T; Xu G; Wang Q; Yang L; Zheng L; Zhao J; Zhang X
Cell Death Dis; 2019 Sep; 10(10):716. PubMed ID: 31558696
[TBL] [Abstract][Full Text] [Related]
13. Correction to: Different apoptotic effects of saxifragifolin C in human breast cancer cells.
Kim KH; Kim JY; Kwak JH; Kim BO; Pyo S
Arch Pharm Res; 2019 Apr; 42(4):373-374. PubMed ID: 30467625
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
15. Author Correction: Genetically engineered cerebral organoids model brain tumor formation.
Bian S; Repic M; Guo Z; Kavirayani A; Burkard T; Bagley JA; Krauditsch C; Knoblich JA
Nat Methods; 2018 Sep; 15(9):748. PubMed ID: 30135560
[TBL] [Abstract][Full Text] [Related]
16. Correction: Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
Anticancer Agents Med Chem; 2019; 19(1):140-142. PubMed ID: 31204622
[TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
Int J Oncol; 2017 Jan; 50(1):340. PubMed ID: 27779677
[TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.
Liu W; Zhang Q; Tang Q; Hu C; Huang J; Liu Y; Lu Y; Wang Q; Li G; Zhang R
Oncol Rep; 2019 Dec; 42(6):2856. PubMed ID: 31638240
[TBL] [Abstract][Full Text] [Related]
19. Correction: PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia.
Koh K; Ichinose Y; Ishiura H; Nan H; Mitsui J; Takahashi J; Sato W; Itoh Y; Hoshino K; Tsuji S; Takiyama Y;
J Hum Genet; 2019 Jan; 64(1):61-63. PubMed ID: 30410098
[TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose‑induced osteoblast dysfunction and hyperglycemia‑induced bone deterioration in mice.
Wu M; Ai W; Chen L; Zhao S; Liu E
Int J Mol Med; 2019 Apr; 43(4):1920. PubMed ID: 30816429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
